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Background: Mycobacterium tuberculosis (Mtb) has evolved multiple mechanisms to manipu-
late its cellular niche for its own advantage. Many efforts have been made to understand
basal mechanisms of mycobacterial infections. However, the underlying molecular regula-
tion is not fully understood. Recently, a new class of non-coding, small RNAs, called
microRNAs (miRNAs), has emerged as important regulators in biological processes, and
their involvement in mycobacterial infection has been identified, thus opening a new field
of research.
Methods: This study aimed to determine by TaqMan Low Density Array the host genome-
wide miRNA expression profile of primary human monocyte-derived macrophages
(MDM) infected with twomembers of theMtb complex: virulentMtb H37Rv and the non-vir-
ulent vaccine strain Mycobacterium bovis Bacillus Calmette-Guerin (BCG) in comparison
with chemically-inactivated Mtb bacilli.
Results: The findings of this study showed that infection of MDM with H37Rv or BCG results
in a signature of miRNA expression mostly overlapping between the two mycobacteria. A
substantially different signature emerged from infection with killed virulent bacilli, sug-
gesting an active influence of live intracellular bacteria on cellular miRNA metabolism.
Specifically, Mtb induced miRNA signature is composed of miRNAs well established in
immune regulation, miR-155 and miR-146a, as well as a set of miRNAs newly associated
with Mtb infection: miR-145, miR-222*, miR-27a and miR-27b. All of these miRNAs are pre-
dicted to target important immune-related genes.
Conclusions: This study signifies the miRNA host response upon intracellular mycobacterial
infection in macrophages, providing new aspects of regulation in host-pathogen interac-
tions, at post-transcriptional levels.
 2013 Published by Elsevier Ltd. on behalf of Asian-African Society for Mycobacteriology.intracellular bacterium, Mtb depends on the tolerance of theIntroduction
To establish an infection in a host organism, Mtb must first
overcome the barriers of the innate immune system [1]. Mac-
rophages are professional phagocytes that provide a first line
of innate immune defense against invading pathogens. As anhed by Elsevier Ltd. on b
85.
rci).
e work presented.host immune system for its survival and replication [2].
Detection of Mtb by macrophages at the cell surface, within
phagosomes, or the cytosol triggers distinct host cell tran-
scriptional responses via pattern recognition receptors
(PRRs) [3–5]. As a consequence, numerous pro-inflammatoryehalf of Asian-African Society for Mycobacteriology.
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struct elicitation of antigen-specific acquired immunity and
clearance of infection. To prevent excessive and inappropriate
activation of the immune system upon infection with an
intracellular pathogen, the host cellular pathways need to
be tightly regulated. MicroRNAs (miRNAs) are significant
modulators of the immune response that function at post-
transcriptional levels [6,7]. Binding of miRNAs to partially
complementary sequences in the 3 0 untranslated region (3 0
UTR) of their respective protein coding mRNA targets leads
to transcript degradation or translational inhibition [8]. MiR-
NA are ‘fine-tuners’ of the immune response – subtle yet
essential regulators in key immune pathways.
A number of recent studies describe the regulations of
mammalian miRNAs in response to bacterial infection.
Helicobacter pylori infection alters the expression of onco-
genes, tumor suppressor genes and miRNAs [9]. Listeria
monocytogenes, a gram-positive facultative intracellular patho-
gen, subvert in bone marrow-derived macrophages the
expression of miR-155, miR-146a, miR-125a-3p/5p, and miR-
149 all of which are implicated in the regulation of immune
related genes [10]. Similarly, infections with the protozoan
parasite Cryptosporidium parvum in epithelial cells [11] or
detection of heat-killed Candida albicans by macrophages [12]
leads to the alteration of host miRNA profile, most likely in-
volved in immunoregulation.
Despite several advancements, tuberculosis remains one
of the most deadly infectious diseases. Recently, the
involvement of miRNAs in mycobacterial infection has been
identified, thus opening a new field of research. Several
Mycobacterium species, including Mycobacterium avium ssp.
Hominissuis, have been shown to actively regulate miRNA
expression in human and murine macrophages during
infection [13] or through the interaction of their antigens
with immune cells. Lipomannan from virulent Mtb has
been shown to be a potent inhibitor of TNFa biosynthesis,
through the regulation of miR-125b and miR-155 expression
in human macrophages [14], while early secreted antigenic
target 6 kDa protein (ESAT-6) exerts strong suppression of
mouse macrophage microbicidal activity through the induc-
tion of miR-155 [15]. Thus, miRNAs – by virtue of their abil-
ity to fine-tune innate immune gene expression – stand out
as candidate regulators of Mtb-induced signaling; however,
there is only sketchy knowledge on their role in guiding
the outcome of host-pathogen interactions and the mecha-
nisms exploited by virulent Mtb to tilt the balance of the in-
nate immune response in its favor, thereby leaving its role
largely unknown. To address this question, this study de-
signed an approach aimed at determining whether the host
genome-wide miRNA profile is altered upon infection of pri-
mary human macrophages infected with two members of
the Mtb complex: virulent Mtb H37Rv and the non-virulent
vaccine strain Mycobacterium bovis Bacillus Calmette-Guerin
(BCG). To distinguish the modulation on miRNA expression
due to passively transferred mycobacterial antigens from
intracellular invasion by metabolically active bacteria, paral-
lel infections with chemically inactivated Mtb bacilli were
initiated.Materials and methods
Isolation of human monocytes and differentiation into MDMs
Unpolarized MDMs were prepared as previously described
[16]. Briefly, leukocyte fractions from peripheral blood of
healthy human donors were obtained from the Ospedale
San Raffaele Blood Center, Milan, Italy. Peripheral blood
mononuclear cells were isolated by density gradient sedimen-
tation using Lympholyte-H (Cederlane, Hornby, Ontario, Can-
ada) andweremaintained in 75 cm2 cell culture flasks (Costar,
Cambridge, MA) in RPMI 1640 medium supplemented with
10% heat-inactivated fetal bovine serum (FBS) and 5% heat-
inactivated human AB serum (all from Lonza, Basel,
Switzerland). After 24 h at 37 C non-adherent cells – mostly
T lymphocytes – were removed by rinsing with PBS-2%FBS
and adherent cells were dislodged with cold PBS by gentle
scraping. Detached cells (P95% monocytes as determined
by flow cytometric analysis after staining with anti-CD14
mAbs) were seeded into 12-well plastic plates (Costar) at the
concentration of 5 · 105 cells/well and cultivated for an addi-
tional 7–8 days in order to obtain macrophages fully differen-
tiated but not polarized [16]. Human study protocols were
approved by the institutional review board at the San Raffaele
Research Institute (Milan, Italy). Written consent was
obtained from all study participants.
Infection assay
MDMs from three different donors were infected with Mtb
H37Rv, M. bovis BCG, or chemically inactivated H37Rv in trip-
licate cultures. M. bovis BCG and Mtb H37Rv (NCTC 7416 and
NCTC 5692; American Type Culture Collection, Manassas,
VA) were grown to mid log phase in Middlebrook 7H9 broth
(Difco Laboratories, Detroit, MI) supplemented with 0.05%
Tween 80 (Sigma) and 10% Middlebrook oleic acid albumin
dextrose catalase enrichment (Becton Dickinson, Sparks,
MD). Chemically killed bacteria were prepared by treatment
with 3% cold formaldehyde for 1hr, followed by extensive
washing with PBS. Formaldehyde treatment, as opposed to
heat inactivation, kills the bacteria but preserves most of
the antigenic structures of the cell [17]. Mycobacteria were
washed twice with PBS, suspended by sonication in RPMI
without antibiotics and used to infect MDMs at multiplicity
of infection (MOI) 5. After 2 h of incubation, MDMs were
washed twice to remove unbound bacilli, cultured for another
24 h and total RNA assayed using TaqMan Low Density Array
v2.0. For each experiment, a chamber slide with mycobacte-
ria-infected macrophage culture was prepared and stained
with Ziehl-Neelsen acid-fast staining in order to check micro-
scopically for intracellular mycobacterial infection.
MiRNA profiling by TaqMan Low Density Array (TLDA)
Total RNA containing the small RNA fraction was isolated
by mirVana miRNA Isolation Kit (Ambion, Austin, Texas)
and RNA quality and concentration measured on the 2100
Bioanalyzer (Agilent, Santa Clara, CA). Average RNA integrity
Fig. 1 – Heat map representation of differentially expressed
miRNAs in MDM infected with M. tuberculosis H37Rv, M.
bovis BCG and M. tuberculosis H37Rv killed. Each column
represents the mean of three different donors and each row
shows miRNAs. The relative up and down-regulation of
miRNAs, expressed as log2 (fold change) is indicated by red
and blue, respectively. OnlymiRNAs significantly modulated
(p < 0.05) with more than two-fold change expression
compared with non-infected MDM are included in the map.
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thesis for TLDA was performed according to manufacturer’s
recommendation. Briefly, 105 ng RNAwas reverse transcribed
using themiRNA reverse transcription kit in combinationwith
stem-loop Megaplex primer pools. MiRNA profiling assays
were performed using TaqMan Low-Density Array v2.0 (Ap-
plied Biosystem, CA, USA). Each sample was analyzed with
an A and B card for the detection of 667 miRNAs together with
endogenous controls. In order to increase the sensitivity of the
TLDA, a pre-amplification was performed after the RT proce-
dure using the TaqMan PreAmp Mastermix and the Megaplex
Pre Amp Primer Pools A+B. qRT-PCR was carried out on a
7900HT Fast Real-Time PCR System (Applied Biosystems).
Statistical analysis
Data analyses were performed using the SDS RQ Manager 1.2
software and DataAssist v2.0 software (Applied Biosystems).
Real-time PCR data on miRNA expression levels were normal-
ized on the most stable candidate endogenous controls se-
lected using the NormFinder algorithm [18]. Fold changes of
miRNA expression relative to the non-infected control were
calculated by the 2DDCT method. Statistical significance of
miRNA expression between infected and non-infected was
determined according to unpaired Student t-test of three bio-
logical replicates.Results and discussion
M. tuberculosis infection in humanmacrophages induces
significant host miRNA expression
In order to identify miRNAs differentially expressed inMtb-in-
fected human macrophages, virulent strain H37Rv was com-
pared with the non-virulent vaccine strain M. bovis BCG,
both extensively characterized in vivo and in vitro. Further-
more, parallel infections with chemically inactivated Mtb
H37Rv bacilli allowed insight as to whether the effects of
Mtb on miRNAs expression required the viable bacteria.
Among the 667 miRNAs characterized in the TLDA assays,
358 (53.6%) distinct miRNAs were expressed in MDMs, either
control or treated, as determined by cycle threshold (Ct) val-
ues of <35. When infected MDMs were compared with un-
treated cells, 52 (14.5%) out of 358 miRNAs were found
significantly different (p < 0.05 unpaired t test of three biolog-
ical replicates) with two-or-more-fold changes in expression
(Fig. 1). Interestingly, as depicted in the Venn diagram in
Fig. 2C, the 52 differentially expressed miRNAs segregated in
discrete groups related to infection conditions. Several gen-
eral observations can be drawn from this data: (i) The largest
group, 26 (51.9%), represents miRNAs modulated in response
to killed H37Rv, of these only 7 were shared with either BCG
or H37Rv, while 19 were specific to killed H37Rv (Fig. 2B and
Fig. 3A); (ii) a pool of 33 miRNAs were modulated in response
to live mycobacteria infection (i.e., H37Rv and BCG), of these
12 were common to both mycobacteria. Three miRNAs for
H37Rv and 4 for BCG were shared with killed H37Rv
(Fig. 2B); and (iii) The last pool included miRNAs specifically
modulated by only one infection condition (Fig. 3A–C).
Fig. 2 – Shared miRNAs expression. (A and B) Represent miRNA commonly expressed in different infection conditions, BCG
white bars, H37Rv gray bars and killed H37Rv black bars. Data represents the mean ± SEM from three biological replicates. (C)
A Venn diagram showing the number of strain specific and shared miRNAs. Only miRNAs significantly modulated (p < 0.05)
with more than two-fold change expression compared with non-infected MDM are included in the diagram. The online tool
Data Overlapping and Area-Proportional Venn Diagram (http://bioinforx.com/free/bxarrays/overlap.php) was used to
generate the Venn diagram. Statistical significance was calculated according to unpaired t test of three biological replicates.
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vigorous modulation of miRNA expression
Infection of human primary macrophages with killed
H37Rv resulted in the strongest miRNA response among
the three infection conditions considered, both in terms
of number of miRNAs and fold change (Fig. 3A). A large
number of statistically significant changes in miRNA abun-
dance induced by killed H37Rv occurred in miRNA passen-
ger strands (marked with an asterisk after the miRNA
name) rather than in the active guide strand (no asterisk).
Passenger strands are usually excluded from miRNA-
induced silencing complex and thus are thought to lack
biological functions [19] although exceptions have been
noted [20]. Alterations in passenger strand abundance were
mirrored by smaller, statistically insignificant changes in
abundance of the corresponding miRNA guide strands in
MDMs (data not shown). These data are consistent with
a recent report by Graff et al. [21] that demonstrated with
kinetic analyses that miRNA passenger strand expression
provides a transient marker for delayed increases in the
functional guide strand miRNA expression following acute
stimulation of macrophages.The set of miRNAs responding to ingestion of killed H37Rv
overlapped only to a small extent (7 miRNAs) with the larger
set responding to viable mycobacteria, Fig. 2B and C. A similar
pattern of gene expression has been previously reported in
mouse macrophage responses to live and inactivated Mtb
[22]. Heat-killed mycobacteria are likely to present carbohy-
drates, glycolipids, and DNA sequences that can be powerful
stimuli for innate immunity. However, the findings of this
study direct attention to those molecules whose production
or release by mycobacteria requires their viability. These in-
clude secreted proteins and lipids, heat-labile proteins and
lipopeptides on the surface, and substances synthesized after
the adaptation of Mtb to the phagosomal environment [23].
A common pool of miRNAs responds in MDM to both virulent
and avirulent mycobacteria infection
From the analysis of this study emerged that during MDM
infection with live mycobacteria, 12 miRNAs were modulated
by bothM. bovis BCG andMtb H37Rv. These changes in miRNA
expression were similar both in terms of strength (fold
change) than direction (up- or down-modulation). Only miR-
145 was different between the two bacteria and just in terms
Fig. 3 – Specific miRNA expression after infection with BCG,
H37Rv and killed H37Rv. (A, B and C) Represent miRNAs
specifically modulated upon infection with, BCG white bars,
H37Rv gray bars and killed H37Rv black bars. Only miRNAs
significantly modulated (p < 0.05) with more than two-fold
change expression compared with non-infected MDM are
included in the diagram. Statistical significance was
calculated according to unpaired t test of three biological
replicates.
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which have proven to be key in many immune and inflamma-
tory pathways was observed in this study [24]. Among the
most characterized miRNAs, miR-155 and miR-146a were sig-nificantly up-regulated both in H37Rv and BCG infected mac-
rophages. This is consistent with recent findings on the
induction of miR-155 and miR-146a by ESAT-6 stimulation of
macrophages [15]. On the other hand, BCG that has lost the
RD1 region and as a consequence the capacity to secrete
ESAT-6, could induce miR-155 through TLR2-triggering [25].
MiR-145 has been recently described as a potent inducer of
apoptosis [26]. It binds to Toll – interleukin-1 receptor domain
– containing adaptor protein (TIRAP) that is known to lie
upstream of tumor necrosis factor receptor – associated fac-
tor-6 (TRAF6), the target of miR-146a, in the innate immune
signaling of myeloid cells [27]. TIRAP is the key upstream acti-
vator of the innate immune cascade in response to TLR2 and
TLR4, while TRAF6 lies at the hub of the pathway activated by
multiple receptors to activate downstream signaling to NF-jB
[28]. As shown in Fig. 1, miR-145 was up-regulated (FC 1.631;
p = 0.317), although non-significantly, upon infection with
killed H37Rv, and this is consistent with a regular inflamma-
tory response of the macrophage. However, upon infection
with BCG, miR-145 was significantly down-regulated (FC
0.3061; p = 0.0469). Loss of miR-145 has been reported to result
in an elevated expression of its targets, TIRAP and inhibition
of apoptosis [27]. Virulent H37Rv infection was associated
with an even lower level of miR-145 (FC 0.1176; p = 0.006) con-
sistent with a lower capacity of virulent Mtb strain to induce
apoptosis [29,30]. Furthermore, miR-27a and miR-27b, which
control inflammation and lipid metabolism through peroxi-
some proliferator-activated receptors (PPARgamma) [31] were
both significantly down-modulated. MiR-222* was strongly
down-modulated; interestingly, miR-222* has been shown to
be strongly reduced in macrophages under M1-polarizing
conditions [21]. This is consistent with previous data report-
ing that during the early phase ofMtb infection, macrophages
are polarized toward an M1 profile [22,32], which is also in
agreement with clinical data collected from patients with ac-
tive tuberculosis [33].
MiRNAs specifically modulated by BCG, H37Rv and killed
H37Rv
Over 52 miRNAs significantly changed in MDM after infection;
three sets of miRNAs modulated specifically by each of the
infection condition were identified.
Infection of MDM with killed H37Rv resulted in the strong
up-regulation of 8 miRNAs (FC range from 31.01 to 37647;
p < 0.05) and down-modulation of 11 miRNAs, most of which
were passenger strands (Fig. 3A). This type of modulation sug-
gests a miRNA response representing a conventional onset of
inflammatory response of infected macrophages. Interest-
ingly, live virulent Mtb H37Rv appeared to elicit a milder
inflammatory activation of the host target cell. Only 4 miR-
NAs were up-regulated and the range of increase was signifi-
cantly smaller (FC range from 2.06 to 4.11; p < 0.05); similarly,
down-modulated miRNAs were 6, of which 4 ranging from
0.2448 to 0.4265; p < 0.05. MiR-503 (FC 0.0637; p = 0.0316) and
miR-551b* (FC 0.0711; p = 0.2649), that represent less charac-
terized miRNAs, showed a more pronounced down-modula-
tion (Fig. 3B). It can be speculated that this set of miRNA,
specifically linked to H37Rv infection, could represent
virulence markers. MiRNAs specifically associated with BCG
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p < 0.05). MiR-645, a less characterized miRNA, was highly
modulated (FC 31.5676; p = 0.0068) (Fig. 3C).
Notably, induction of miR-29a, miR-125b and miR-21
[14,34,13], previously reported to be linked to mycobacterial
infection, was not confirmed in our experimental system.
Conclusions
This study reports the first genome-wide Mtb infection in-
duced miRNA expression profile in primary human macro-
phages. The findings show that infection of human
macrophages with virulent Mtb H37Rv and avirulent M. bovis
BCG results in a pattern of miRNA expression mostly overlap-
ping between the two live mycobacteria considered, while a
substantially different pattern emerged from infection with
killed Mtb bacilli suggesting an active influence of live intra-
cellular bacteria on cell target miRNA-metabolism.
The Mtb-induced miRNA signature was composed of the
well established in immune regulation miR-155 and miR-
146a, as well as a set of miRNAs newly associated with Mtb
infection: miR-145, miR-222* and miR-27a, miR-27b, all of
which are predicted to target important immune-related
genes. Moreover, a set of less characterized miRNAs were
identified, which are elicited only by virulent H37Rv infection.
This study signifies the miRNA host response upon intracellu-
lar Mtb complex spp. infection in macrophages, providing
new aspects of regulation in host-pathogen interactions, at
post-transcriptional levels.
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